Description
========================
TIRZEPATIDE — Research Dual Incretin Agonist (GLP-1/GIP)
========================
Class: “Twincretin” (GLP-1R + GIPR agonism); metabolic research
Research Focus (non-clinical):
• Dual-receptor synergy: glycemic control + energy balance
• HbA1c/weight-related research endpoints in model systems
• Combination strategies with insulin or other agents
Notes for Investigators:
Used to study multi-hormonal modulation of glucose and body-weight pathways; avoid clinical positioning in storefront copy. :contentReference[oaicite:33]{index=33} :contentReference[oaicite:34]{index=34}
Regulatory & Use
• Laboratory research only. Not for human or veterinary use. No therapeutic or dosing claims. :contentReference[oaicite:35]{index=35}
